The drug company Eli Lilly is about to start testing its Covid-19 antibody drug in nursing homes. Vaccines may not work as well on elderly people or those with compromised immune systems. Since these are the very groups most at risk for severe disease or death if they contract the coronavirus, a successful antibody treatment could have a marked effect on lowering the pandemic’s death toll. Riley Griffin talks about the new drug, and the promise of antibody treatments.
See omnystudio.com/listener for privacy information.